Ensysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Pain
~ PF614 Phase 3 Program Expected to Begin Enrollment in Mid-2024 ~SAN DIEGO, CA / ACCESSWIRE / January 31, 2024
~ PF614 Phase 3 Program Expected to Begin Enrollment in Mid-2024 ~SAN DIEGO, CA / ACCESSWIRE / January 31, 2024
MONTRÉAL, QC / ACCESSWIRE / le 31 janvier 2024 / Valsoft Corporation inc. (« Valsoft »), société canadienne spécialisée dans
MONTREAL, QC / ACCESSWIRE / January 31, 2024 / Valsoft Corporation Inc. (“Valsoft”), a Canadian company specializing in the acquisition
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / January 31, 2024 / Gaining an advantage might be crucial in the rapidly evolving
Sustainable Retail Packaging Solution Replaces EPS On Processor Production LinesCHARLOTTE, NC / ACCESSWIRE / January 31, 2024 / In its
TORONTO, ON / ACCESSWIRE / January 31, 2024 / Canada Jetlines Operations Ltd. (Cboe CA:CJET) (“Canada Jetlines” or the “Company”)
CAYMAN ISLANDS / ACCESSWIRE / January 31, 2024 / The QRDO Foundation, dedicated to the growth and development of the
VANCOUVER, BC / ACCESSWIRE / January 31, 2024 / Pegasus Resources Inc. (TSXV:PEGA)(Frankfurt:0QS0)(OTC Pink Sheet symbol:SLTFF) (the “Company” or “Pegasus”)
Copyright 2024 © Egypt Gazette All rights Reserved.